DAMPs activating innate immune responses in sepsis

Ageing Research Reviews

Volumn 24, Issue , 2015, Pages 54-65

  Kang, Jung Woo ^a   Kim, So Jin ^a   Cho, Hong Ik ^a   Lee, Sun Mee ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Damage associated molecular patterns; Innate immune system; Pattern recognition receptors; Sepsis

Indexed keywords

CELL PROTEIN; DAMAGE ASSOCIATED MOLECULAR PATTERN PROTEIN; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 33; MITOCHONDRIAL DNA; NUCLEOPHOSMIN; UNCLASSIFIED DRUG; PATTERN RECOGNITION RECEPTOR;

CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOTHELIUM CELL; HUMAN; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; MACROPHAGE; MITOCHONDRION; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PROTEIN SECRETION; REVIEW; SEPSIS; AGING; ANIMAL; IMMUNOLOGY; METABOLISM; PATHOLOGY;

AGING; ANIMALS; HUMANS; IMMUNITY, INNATE; RECEPTORS, PATTERN RECOGNITION; SEPSIS;

EID: 84947034011     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2015.03.003     Document Type: Review

References (188)

1. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
2. Alexander H.R., Doherty G.M., Buresh C.M., Venzon D.J., Norton J.A. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 1991, 173:1029-1032.
3. Ali S., Huber M., Kollewe C., Bischoff S.C., Falk W., Martin M.U. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:18660-18665.
4. Alves-Filho J.C., Sonego F., Souto F.O., Freitas A., Verri W.A., Auxiliadora-Martins M., Basile-Filho A., McKenzie A.N., Xu D., Cunha F.Q., Liew F.Y. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat. Med. 2010, 16:708-712.
5. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., Smith A.J., Staden R., Young I.G. Sequence and organization of the human mitochondrial genome. Nature 1981, 290:457-465.
6. Andersson U., Tracey K.J. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis. Rheum. Dis. Clin. North Am. 2004, 30(XI):627-637.
7. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29:1303-1310.
8. Angus D.C., Wax R.S. Epidemiology of sepsis: an update. Crit. Care Med. 2001, 29:S109-116.
9. Arend W.P., Malyak M., Guthridge C.J., Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 1998, 16:27-55.
10. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O., Auron P.E., Stevenson M.A., Calderwood S.K. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 2002, 277:15028-15034.
11. Bartz R.R., Suliman H.B., Fu P., Welty-Wolf K., Carraway M.S., MacGarvey N.C., Withers C.M., Sweeney T.E., Piantadosi C.A. Staphylococcus aureus sepsis and mitochondrial accrual of the 8-oxoguanine DNA glycosylase DNA repair enzyme in mice. Am. J. Respir. Crit. Care Med. 2011, 183:226-233.
12. Bianchi M.E., Beltrame M. Flexing DNA: HMG-box proteins and their partners. Am. J. Hum. Genet. 1998, 63:1573-1577.
13. Bianchi M.E., Beltrame M., Paonessa G. Specific recognition of cruciform DNA by nuclear protein HMG1. Science 1989, 243:1056-1059.
14. Bianchi M.E., Falciola L., Ferrari S., Lilley D.M. The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J. 1992, 11:1055-1063.
15. Bielecka-Dabrowa A., Barylski M., Mikhailidis D.P., Rysz J., Banach M. HSP 70 and atherosclerosis - protector or activator?. Expert Opin. Ther. Targets 2009, 13:307-317.
16. Bogenhagen D.F. Does mtDNA nucleoid organization impact aging?. Exp. Gerontol. 2010, 45:473-477.
17. Bopp C., Bierhaus A., Hofer S., Bouchon A., Nawroth P.P., Martin E., Weigand M.A. Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit. Care 2008, 12:201.
18. Buryskova M., Pospisek M., Grothey A., Simmet T., Burysek L. Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes. J. Biol. Chem. 2004, 279:4017-4026.
19. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol. 1999, 19:5237-5246.
20. Calogero S., Grassi F., Aguzzi A., Voigtlander T., Ferrier P., Ferrari S., Bianchi M.E. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 1999, 22:276-280.
21. Campion G.V., Lebsack M.E., Lookabaugh J., Gordon G., Catalano M. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group. Arthritis Rheum. 1996, 39:1092-1101.
22. Carchman E.H., Whelan S., Loughran P., Mollen K., Stratamirovic S., Shiva S., Rosengart M.R., Zuckerbraun B.S. Experimental sepsis-induced mitochondrial biogenesis is dependent on autophagy, TLR4, and TLR9 signaling in liver. FASEB J. 2013, 27:4703-4711.
23. Castellheim A., Brekke O.L., Espevik T., Harboe M., Mollnes T.E. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand. J. Immunol. 2009, 69:479-491.
24. Cayrol C., Girard J.P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9021-9026.
25. Chatterjee A., Dimitropoulou C., Drakopanayiotakis F., Antonova G., Snead C., Cannon J., Venema R.C., Catravas J.D. Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis. Am. J. Respir. Crit. Care Med. 2007, 176:667-675.
26. Chatterjee A., Snead C., Yetik-Anacak G., Antonova G., Zeng J., Catravas J.D. Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. Am. J. Physiol. Lung Cell Mol. Physiol. 2008, 294:L755-763.
27. Chen C.J., Kono H., Golenbock D., Reed G., Akira S., Rock K.L. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 2007, 13:851-856.
28. Chen G., Li J., Ochani M., Rendon-Mitchell B., Qiang X., Susarla S., Ulloa L., Yang H., Fan S., Goyert S.M., Wang P., Tracey K.J., Sama A.E., Wang H. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J. Leukoc. Biol. 2004, 76:994-1001.
29. Chen X.J., Butow R.A. The organization and inheritance of the mitochondrial genome. Nat. Rev. Genet. 2005, 6:815-825.
30. Chiang N., Fierro I.M., Gronert K., Serhan C.N. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 2000, 191:1197-1208.
31. Chorny A., Delgado M. Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1. Am. J. Pathol. 2008, 172:1297-1307.
32. Crouser E.D., Shao G., Julian M.W., Macre J.E., Shadel G.S., Tridandapani S., Huang Q., Wewers M.D. Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Crit. Care Med. 2009, 37:2000-2009.
33. De Gaudio A.R., Rinaldi S., Chelazzi C., Borracci T. Pathophysiology of sepsis in the elderly: clinical impact and therapeutic considerations. Curr. Drug Targets 2009, 10:60-70.
34. Degryse B., Bonaldi T., Scaffidi P., Muller S., Resnati M., Sanvito F., Arrigoni G., Bianchi M.E. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 2001, 152:1197-1206.
35. Dewan S.K., Zheng S.B., Xia S.J., Bill K. Senescent remodeling of the immune system and its contribution to the predisposition of the elderly to infections. Chin. Med. J. (Engl.) 2012, 125:3325-3331.
36. Dinarello C.A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 1998, 16:457-499.
37. Dinarello C.A. Anti-cytokine therapies in response to systemic infection. J. Investig. Dermatol. Symp. Proc. 2001, 6:244-250.
38. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
39. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732.
40. Dombrovskiy V.Y., Martin A.A., Sunderram J., Paz H.L. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit. Care Med. 2007, 35:1244-1250.
41. Dupont N., Jiang S., Pilli M., Ornatowski W., Bhattacharya D., Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J. 2011, 30:4701-4711.
42. Dybdahl B., Wahba A., Lien E., Flo T.H., Waage A., Qureshi N., Sellevold O.F., Espevik T., Sundan A. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 2002, 105:685-690.
43. Eigenbrod T., Park J.H., Harder J., Iwakura Y., Nunez G. Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J. Immunol. 2008, 181:8194-8198.
44. Einck L., Bustin M. The intracellular distribution and function of the high mobility group chromosomal proteins. Exp. Cell Res. 1985, 156:295-310.
45. Falciola L., Spada F., Calogero S., Langst G., Voit R., Grummt I., Bianchi M.E. High mobility group 1 protein is not stably associated with the chromosomes of somatic cells. J. Cell Biol. 1997, 137:19-26.
46. Feldman N., Rotter-Maskowitz A., Okun E. DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res. Rev. 2015.
47. Fida N.M., Al-Mughales J., Farouq M. Interleukin-1alpha, interleukin-6 and tumor necrosis factor-alpha levels in children with sepsis and meningitis. Pediatr. Int. 2006, 48:118-124.
48. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002, 3:995-1001.
49. Gelain D.P., de Bittencourt Pasquali M.A., M.Comim C., Grunwald M.S., Ritter C., Tomasi C.D., Alves S.C., Quevedo J., Dal-Pizzol F., Moreira J.C. Serum heat shock protein 70 levels, oxidant status, and mortality in sepsis. Shock 2011, 35:466-470.
50. Giese K., Cox J., Grosschedl R. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 1992, 69:185-195.
51. Gillespie J., Mathews R., McDermott M.F. Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS). J. Inflamm. Res. 2010, 3:1-8.
52. Gomez C.R., Nomellini V., Faunce D.E., Kovacs E.J. Innate immunity and aging. Exp. Gerontol. 2008, 43:718-728.
53. Grisendi S., Bernardi R., Rossi M., Cheng K., Khandker L., Manova K., Pandolfi P.P. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005, 437:147-153.
54. Gross O., Yazdi A.S., Thomas C.J., Masin M., Heinz L.X., Guarda G., Quadroni M., Drexler S.K., Tschopp J. Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 2012, 36:388-400.
55. Grubeck-Loebenstein B., Berger P., Saurwein-Teissl M., Zisterer K., Wick G. No immunity for the elderly. Nat. Med. 1998, 4:870.
56. Ha Y.M., Ham S.A., Kim Y.M., Lee Y.S., Kim H.J., Seo H.G., Lee J.H., Park M.K., Chang K.C. Beta(1)-adrenergic receptor-mediated HO-1 induction, via PI3K and p38 MAPK: by isoproterenol in RAW 264.7 cells leads to inhibition of HMGB1 release in LPS-activated RAW 264.7 cells and increases in survival rate of CLP-induced septic mice. Biochem. Pharmacol. 2011, 82:769-777.
57. Haden D.W., Suliman H.B., Carraway M.S., Welty-Wolf K.E., Ali A.S., Shitara H., Yonekawa H., Piantadosi C.A. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am. J. Respir. Crit. Care Med. 2007, 176:768-777.
58. Hajizadeh S., DeGroot J., TeKoppele J.M., Tarkowski A., Collins L.V. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res. Ther. 2003, 5:R234-240.
59. Hall M.W., Knatz N.L., Vetterly C., Tomarello S., Wewers M.D., Volk H.D., Carcillo J.A. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011, 37:525-532.
60. Harris H.E., Raucci A. Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep. 2006, 7:774-778.
61. Hashiguchi N., Ogura H., Tanaka H., Koh T., Nakamori Y., Noborio M., Shiozaki T., Nishino M., Kuwagata Y., Shimazu T., Sugimoto H. Enhanced expression of heat shock proteins in activated polymorphonuclear leukocytes in patients with sepsis. J. Trauma 2001, 51:1104-1109.
62. Hatada T., Wada H., Nobori T., Okabayashi K., Maruyama K., Abe Y., Uemoto S., Yamada S., Maruyama I. Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb. Haemost. 2005, 94:975-979.
63. Hightower L.E., Guidon P.T. Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia-axon transfer proteins. J. Cell Physiol. 1989, 138:257-266.
64. Holt I.J., He J., Mao C.C., Boyd-Kirkup J.D., Martinsson P., Sembongi H., Reyes A., Spelbrink J.N. Mammalian mitochondrial nucleoids: organizing an independently minded genome. Mitochondrion 2007, 7:311-321.
65. Hoogerwerf J.J., Tanck M.W., van Zoelen M.A., Wittebole X., Laterre P.F., van der Poll T. Soluble ST2 plasma concentrations predict mortality in severe sepsis. Intensive Care Med. 2010, 36:630-637.
66. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348:138-150.
67. Hotchkiss R.S., Monneret G., Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 2013, 13:260-268.
68. Hou C., Zhao H., Li W., Liang Z., Zhang D., Liu L., Tong W., Cai S.X., Zou F. Increased heat shock protein 70 levels in induced sputum and plasma correlate with severity of asthma patients. Cell Stress Chaperon. 2011, 16:663-671.
69. Hsu J.H., Yang R.C., Lin S.J., Liou S.F., Dai Z.K., Yeh J.L., Wu J.R. Exogenous heat shock cognate protein 70 pretreatment attenuates cardiac and hepatic dysfunction with associated anti-inflammatory responses in experimental septic shock. Shock 2014, 42:540-547.
70. Hu Y.M., Pai M.H., Yeh C.L., Hou Y.C., Yeh S.L. Glutamine administration ameliorates sepsis-induced kidney injury by downregulating the high-mobility group box protein-1-mediated pathway in mice. Am. J. Physiol. Renal Physiol. 2012, 302:F150-158.
71. Huang J., Xie Y., Sun X., Zeh H.J., Kang R., Lotze M.T., Tang D. DAMPs, ageing, and cancer: the 'DAMP Hypothesis'. Ageing Res. Rev. 2014.
72. Husak L., Marcuzzi A., Herring J., Wen E., Yin L., Capan D.D., Cernat G. National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada. Healthc Q. 2010, 13:35-41. Spec No.
73. Huttunen H.J., Fages C., Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 1999, 274:19919-19924.
74. Ivanov S., Dragoi A.M., Wang X., Dallacosta C., Louten J., Musco G., Sitia G., Yap G.S., Wan Y., Biron C.A., Bianchi M.E., Wang H., Chu W.M. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007, 110:1970-1981.
75. Jog N.R., Dinnall J.A., Gallucci S., Madaio M.P., Caricchio R. Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation. J. Immunol. 2009, 182:7297-7306.
76. Joosten L.A., Van De Veerdonk F.L., Vonk A.G., Boerman O.C., Keuter M., Fantuzzi G., Verschueren I., Van Der Poll T., Dinarello C.A., Kullberg B.J., Van Der Meer J.W., Netea M.G. Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1alpha, IL-1beta or IL-1 receptor type I. APMIS 2010, 118:1000-1007.
77. Jung K., Lee J.E., Kim H.Z., Kim H.M., Park B.S., Hwang S.I., Lee J.O., Kim S.C., Koh G.Y. Toll-like receptor 4 decoy, TOY, attenuates gram-negative bacterial sepsis. PLoS ONE 2009, 4:e7403.
78. Kang R., Livesey K.M., Zeh H.J., Lotze M.T., Tang D. HMGB1 as an autophagy sensor in oxidative stress. Autophagy 2011, 7:904-906.
79. Kim J.H., Kim S.J., Lee I.S., Lee M.S., Uematsu S., Akira S., Oh K.I. Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway. J. Immunol. 2009, 182:2458-2466.
80. Kim T.H., Kim S.J., Lee S.M. Stimulation of the alpha7 nicotinic acetylcholine receptor protects against sepsis by inhibiting Toll-like receptor via phosphoinositide 3-kinase activation. J. Infect. Dis. 2014, 209:1668-1677.
81. Kim T.H., Yoon S.J., Lee S.M. Genipin attenuates sepsis by inhibiting Toll-like receptor signaling. Mol. Med. 2012, 18:455-465.
82. Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290:1717-1721.
83. Kornblit B., Munthe-Fog L., Madsen H.O., Strom J., Vindelov L., Garred P. Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit. Care 2008, 12:R83.
84. Krabbe K.S., Bruunsgaard H., Qvist J., Hansen C.M., Moller K., Fonsmark L., Madsen P.L., Kronborg G., Frandsen U., Andersen H.O., Skinhoj P., Pedersen B.K. Hypotension during endotoxemia in aged humans. Eur. J. Anaesthesiol. 2001, 18:572-575.
85. Kregel K.C. Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J. Appl. Physiol. 1985, 92:2177-2186.
86. Kumar V., Harjai K., Chhibber S. A combination of thalidomide and augmentin protects BALB/c mice suffering from Klebsiella pneumoniae B5055-induced sepsis. J. Chemother. 2009, 21:159-164.
87. Kung C.T., Hsiao S.Y., Tsai T.C., Su C.M., Chang W.N., Huang C.R., Wang H.C., Lin W.C., Chang H.W., Lin Y.J., Cheng B.C., Su B.Y., Tsai N.W., Lu C.H. Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room. J. Transl. Med. 2012, 10:130.
88. Kuroiwa K., Arai T., Okazaki H., Minota S., Tominaga S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem. Biophys. Res. Commun. 2001, 284:1104-1108.
89. Lamkanfi M., Dixit V.M. IL-33 raises alarm. Immunity 2009, 31:5-7.
90. Lancaster G.I., Febbraio M.A. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J. Biol. Chem. 2005, 280:23349-23355.
91. Landsman D., Bustin M. A signature for the HMG-1 box DNA-binding proteins. Bioessays 1993, 15:539-546.
92. Lau A., Wang S., Jiang J., Haig A., Pavlosky A., Linkermann A., Zhang Z.X., Jevnikar A.M. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am. J. Transplant. 2013, 13:2805-2818.
93. Le Tulzo Y., Pangault C., Gacouin A., Guilloux V., Tribut O., Amiot L., Tattevin P., Thomas R., Fauchet R., Drenou B. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002, 18:487-494.
94. LeBlanc P.M., Doggett T.A., Choi J., Hancock M.A., Durocher Y., Frank F., Nagar B., Ferguson T.A., Saleh M. An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor. J. Biol. Chem. 2014, 289:7777-7786.
95. Lee C.H., Yoon S.J., Lee S.M. Chlorogenic acid attenuates high mobility group box 1 (HMGB1) and enhances host defense mechanisms in murine sepsis. Mol. Med. 2012, 18:1437-1448.
96. Lefrancais E., Roga S., Gautier V., Gonzalez-de-Peredo A., Monsarrat B., Girard J.P., Cayrol C. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:1673-1678.
97. Li J., Kokkola R., Tabibzadeh S., Yang R., Ochani M., Qiang X., Harris H.E., Czura C.J., Wang H., Ulloa L., Wang H., Warren H.S., Moldawer L.L., Fink M.P., Andersson U., Tracey K.J., Yang H. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol. Med. 2003, 9:37-45.
98. Li W., Zhu S., Li J., Assa A., Jundoria A., Xu J., Fan S., Eissa N.T., Tracey K.J., Sama A.E., Wang H. EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem. Pharmacol. 2011, 81:1152-1163.
99. Liew F.Y., Pitman N.I., McInnes I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010, 10:103-110.
100. Liliensiek B., Weigand M.A., Bierhaus A., Nicklas W., Kasper M., Hofer S., Plachky J., Grone H.J., Kurschus F.C., Schmidt A.M., Yan S.D., Martin E., Schleicher E., Stern D.M., Hammerling G.G., Nawroth P.P., Arnold B. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 2004, 113:1641-1650.
101. Liu F., Yao Y.M., Dong N., Xu S., Sheng Z.Y. [The receptor mechanism of high mobility group box-1 protein induced apoptosis in peritoneal macrophages in mice]. Zhonghua Shao Shang Za Zhi 2007, 23:432-435.
102. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 2005, 5:331-342.
103. Luthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., Brumatti G., Taylor R.C., Kersse K., Vandenabeele P., Lavelle E.C., Martin S.J. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
104. Lutterloh E.C., Opal S.M., Pittman D.D., Keith J.C., Tan X.Y., Clancy B.M., Palmer H., Milarski K., Sun Y., Palardy J.E., Parejo N.A., Kessimian N. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit. Care 2007, 11:R122.
105. Ma L., Kim S.J., Oh K.I. CAlcium/calmodulin-dependent protein kinase is involved in the release of high mobility group box 1 via the interferon-beta signaling pathway. Immune Netw. 2012, 12:148-154.
106. Mambula S.S., Stevenson M.A., Ogawa K., Calderwood S.K. Mechanisms for Hsp70 secretion: crossing membranes without a leader. Methods 2007, 43:168-175.
107. Mantell L.L., Parrish W.R., Ulloa L. Hmgb-1 as a therapeutic target for infectious and inflammatory disorders. Shock 2006, 25:4-11.
108. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 2003, 348:1546-1554.
109. Martin G.S., Mannino D.M., Moss M. The effect of age on the development and outcome of adult sepsis. Crit. Care Med. 2006, 34:15-21.
110. Matzinger P. An innate sense of danger. Semin. Immunol. 1998, 10:399-415.
111. Maugeri N., Rovere-Querini P., Baldini M., Baldissera E., Sabbadini M.G., Bianchi M.E., Manfredi A.A. Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis. Antioxid Redox Signal 2014, 20:1060-1074.
112. McConnell K.W., Fox A.C., Clark A.T., Chang N.Y., Dominguez J.A., Farris A.B., Buchman T.G., Hunt C.R., Coopersmith C.M. The role of heat shock protein 70 in mediating age-dependent mortality in sepsis. J. Immunol. 2011, 186:3718-3725.
113. Meisel C., Schefold J.C., Pschowski R., Baumann T., Hetzger K., Gregor J., Weber-Carstens S., Hasper D., Keh D., Zuckermann H., Reinke P., Volk H.D. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am. J. Respir. Crit. Care Med. 2009, 180:640-648.
114. Miller R.A. The aging immune system: primer and prospectus. Science 1996, 273:70-74.
115. Moussion C., Ortega N., Girard J.P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?. PLoS ONE 2008, 3:e3331.
116. Muller B., Peri G., Doni A., Perruchoud A.P., Landmann R., Pasqualini F., Mantovani A. High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J. Leukoc. Biol. 2002, 72:643-649.
117. Muller S., Scaffidi P., Degryse B., Bonaldi T., Ronfani L., Agresti A., Beltrame M., Bianchi M.E. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 2001, 20:4337-4340.
118. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., Englert J.A., Rabinovitch M., Cernadas M., Kim H.P., Fitzgerald K.A., Ryter S.W., Choi A.M. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011, 12:222-230.
119. Nawa Y., Kawahara K., Tancharoen S., Meng X., Sameshima H., Ito T., Masuda Y., Imaizumi H., Hashiguchi T., Maruyama I. Nucleophosmin may act as an alarmin: implications for severe sepsis. J. Leukoc. Biol. 2009, 86:645-653.
120. Netea M.G., van de Veerdonk F.L., Kullberg B.J., Van der Meer J.W., Joosten L.A. The role of NLRs and TLRs in the activation of the inflammasome. Expert Opin. Biol. Ther. 2008, 8:1867-1872.
121. Oboki K., Ohno T., Kajiwara N., Arae K., Morita H., Ishii A., Nambu A., Abe T., Kiyonari H., Matsumoto K., Sudo K., Okumura K., Saito H., Nakae S. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18581-18586.
122. Oh Y.J., Youn J.H., Ji Y., Lee S.E., Lim K.J., Choi J.E., Shin J.S. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J. Immunol. 2009, 182:5800-5809.
123. Oshikawa K., Kuroiwa K., Tago K., Iwahana H., Yanagisawa K., Ohno S., Tominaga S.I., Sugiyama Y. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Respir. Crit. Care Med. 2001, 164:277-281.
124. Ostrov V.F., Evgen'ev M.B., Murashev A.N. Influence of the recombinant human 70-kDa heat-shock protein on simulation of gram-positive sepsis in rats. Dokl. Biol. Sci. 2011, 437:65-68.
125. Palumbo R., Galvez B.G., Pusterla T., De Marchis F., Cossu G., Marcu K.B., Bianchi M.E. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J. Cell Biol. 2007, 179:33-40.
126. Park E.J., Jang H.J., Tsoyi K., Kim Y.M., Park S.W., Kim H.J., Lee J.H., Chang K.C. The heme oxygenase-1 inducer THI-56 negatively regulates iNOS expression and HMGB1 release in LPS-activated RAW 264.7 cells and CLP-induced septic mice. PLoS ONE 2013, 8:e76293.
127. Park J.S., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J.Y., Strassheim D., Sohn J.W., Yamada S., Maruyama I., Banerjee A., Ishizaka A., Abraham E. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 2006, 290:C917-924.
128. Parrish W., Ulloa L. High-mobility group box-1 isoforms as potential therapeutic targets in sepsis. Methods Mol. Biol. 2007, 361:145-162.
129. Pavlosky A., Lau A., Su Y., Lian D., Huang X., Yin Z., Haig A., Jevnikar A.M., Zhang Z.X. RIPK3-mediated necroptosis regulates cardiac allograft rejection. Am. J. Transplant. 2014, 14:1778-1790.
130. Pockley A.G., Wu R., Lemne C., Kiessling R., de Faire U., Frostegard J. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 2000, 36:303-307.
131. Qin S., Wang H., Yuan R., Li H., Ochani M., Ochani K., Rosas-Ballina M., Czura C.J., Huston J.M., Miller E., Lin X., Sherry B., Kumar A., Larosa G., Newman W., Tracey K.J., Yang H. Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 2006, 203:1637-1642.
132. Rabiet M.J., Huet E., Boulay F. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur. J. Immunol. 2005, 35:2486-2495.
133. Schiffmann E., Corcoran B.A., Wahl S.M. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc. Natl. Acad. Sci. U. S. A. 1975, 72:1059-1062.
134. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., Kastelein R.A. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
135. Scott A.M., Saleh M. The inflammatory caspases: guardians against infections and sepsis. Cell Death Differ. 2007, 14:23-31.
136. Selvatici R., Falzarano S., Mollica A., Spisani S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur. J. Pharmacol. 2006, 534:1-11.
137. Seong S.Y., Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004, 4:469-478.
138. Shah K.G., Wu R., Jacob A., Molmenti E.P., Nicastro J., Coppa G.F., Wang P. Recombinant human milk fat globule-EGF factor 8 produces dose-dependent benefits in sepsis. Intensive Care Med. 2012, 38:128-136.
139. Shimpo M., Morrow D.A., Weinberg E.O., Sabatine M.S., Murphy S.A., Antman E.M., Lee R.T. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 2004, 109:2186-2190.
140. Singleton K.D., Wischmeyer P.E. Effects of HSP70.1/3 gene knockout on acute respiratory distress syndrome and the inflammatory response following sepsis. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 290:L956-961.
141. Sparvero L.J., Asafu-Adjei D., Kang R., Tang D., Amin N., Im J., Rutledge R., Lin B., Amoscato A.A., Zeh H.J., Lotze M.T. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J. Transl. Med. 2009, 7:17.
142. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2002, 2:185-194.
143. Starr M.E., Saito H. Sepsis in old age: review of human and animal studies. Aging Dis. 2014, 5:126-136.
144. Suliman H.B., Welty-Wolf K.E., Carraway M., Tatro L., Piantadosi C.A. Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc, Res 2004, 64:279-288.
145. Sundar K.M., Sires M. Sepsis induced immunosuppression: implications for secondary infections and complications. Indian J. Crit. Care Med. 2013, 17:162-169.
146. Sunden-Cullberg J., Norrby-Teglund A., Rouhiainen A., Rauvala H., Herman G., Tracey K.J., Lee M.L., Andersson J., Tokics L., Treutiger C.J. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med. 2005, 33:564-573.
147. Sweeney T.E., Suliman H.B., Hollingsworth J.W., Piantadosi C.A. Differential regulation of the PGC family of genes in a mouse model of Staphylococcus aureus sepsis. PLoS ONE 2010, 5:e11606.
148. Tadie J.M., Bae H.B., Banerjee S., Zmijewski J.W., Abraham E. Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing. Am. J. Physiol. Cell Physiol. 2012, 302:C249-256.
149. Tadros T., Traber D.L., Heggers J.P., Herndon D.N. Effects of interleukin-1alpha administration on intestinal ischemia and reperfusion injury, mucosal permeability, and bacterial translocation in burn and sepsis. Ann. Surg. 2003, 237:101-109.
150. Talabot-Ayer D., Lamacchia C., Gabay C., Palmer G. Interleukin-33 is biologically active independently of caspase-1 cleavage. J. Biol. Chem. 2009, 284:19420-19426.
151. Tang D., Kang R., Livesey K.M., Cheh C.W., Farkas A., Loughran P., Hoppe G., Bianchi M.E., Tracey K.J., Zeh H.J., Lotze M.T. Endogenous HMGB1 regulates autophagy. J. Cell Biol. 2010, 190:881-892.
152. Tang D., Kang R., Zeh H.J., Lotze M.T. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal 2011, 14:1315-1335.
153. Tang Y., Lv B., Wang H., Xiao X., Zuo X. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia. Int. Immunopharmacol. 2008, 8:1646-1651.
154. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L.L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M.K., Fitzgerald K.A., Latz E., Kiener P.A., Coyle A.J. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 2007, 8:487-496.
155. Tsan M.F., Gao B. Cytokine function of heat shock proteins. Am. J. Physiol. Cell Physiol. 2004, 286:C739-744.
156. Tsung A., Klune J.R., Zhang X., Jeyabalan G., Cao Z., Peng X., Stolz D.B., Geller D.A., Rosengart M.R., Billiar T.R. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med. 2007, 204:2913-2923.
157. Turnbull I.R., Buchman T.G., Javadi P., Woolsey C.A., Hotchkiss R.S., Karl I.E., Coopersmith C.M. Age disproportionately increases sepsis-induced apoptosis in the spleen and gut epithelium. Shock 2004, 22:364-368.
158. Ueno H., Matsuda T., Hashimoto S., Amaya F., Kitamura Y., Tanaka M., Kobayashi A., Maruyama I., Yamada S., Hasegawa N., Soejima J., Koh H., Ishizaka A. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am. J. Respir. Crit. Care Med. 2004, 170:1310-1316.
159. Ueno T., Ikeda T., Ikeda K., Taniuchi H., Suda S., Yeung M.Y., Matsuno N. HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP. J. Surg. Res. 2011, 171:183-190.
160. Urbonaviciute V., Furnrohr B.G., Meister S., Munoz L., Heyder P., De Marchis F., Bianchi M.E., Kirschning C., Wagner H., Manfredi A.A., Kalden J.R., Schett G., Rovere-Querini P., Herrmann M., Voll R.E. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 2008, 205:3007-3018.
161. van Zoelen M.A., Schmidt A.M., Florquin S., Meijers J.C., de Beer R., de Vos A.F., Nawroth P.P., Bierhaus A., van der Poll T. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. J. Infect. Dis. 2009, 200:765-773.
162. Walsh K.B., Toledo A.H., Rivera-Chavez F.A., Lopez-Neblina F., Toledo-Pereyra L.H. Inflammatory mediators of liver ischemia-reperfusion injury. Exp. Clin. Transplant 2009, 7:78-93.
163. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
164. Wang H., Ward M.F., Sama A.E. Targeting HMGB1 in the treatment of sepsis. Expert Opin. Ther. Targets 2014, 18:257-268.
165. Wang H., Zhu S., Zhou R., Li W., Sama A.E. Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev. Mol. Med. 2008, 10:e32.
166. Wang Y., Bogenhagen D.F. Human mitochondrial DNA nucleoids are linked to protein folding machinery and metabolic enzymes at the mitochondrial inner membrane. J. Biol. Chem. 2006, 281:25791-25802.
167. Wenceslau C.F., McCarthy C.G., Goulopoulou S., Szasz T., NeSmith E.G., Webb R.C. Mitochondrial-derived N-formyl peptides: novel links between trauma, vascular collapse and sepsis. Med. Hypotheses 2013, 81:532-535.
168. West M.D., Pereira-Smith O.M., Smith J.R. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp. Cell Res. 1989, 184:138-147.
169. Wheeler D.S., Fisher L.E., Catravas J.D., Jacobs B.R., Carcillo J.A., Wong H.R. Extracellular hsp70 levels in children with septic shock. Pediatr. Crit. Care Med. 2005, 6:308-311.
170. Wheeler D.S., Lahni P., Odoms K., Jacobs B.R., Carcillo J.A., Doughty L.A., Wong H.R. Extracellular heat shock protein 60 (Hsp60) levels in children with septic shock. Inflamm. Res. 2007, 56:216-219.
171. Whitham M., Fortes M.B. Heat shock protein 72: release and biological significance during exercise. Front. Biosci. 2008, 13:1328-1339.
172. Wiersinga W.J., Leopold S.J., Cranendonk D.R., van der Poll T. Host innate immune responses to sepsis. Virulence 2014, 5:36-44.
173. Xu H., Su Z., Wu J., Yang M., Penninger J.M., Martin C.M., Kvietys P.R., Rui T. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway. J. Immunol. 2010, 184:1492-1498.
174. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1547-1559.
175. Xu W., Lu Y., Yao J., Li Z., Chen Z., Wang G., Jing H., Zhang X., Li M., Peng J., Tian X. Novel role of resveratrol: suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury. Shock 2014, 42:440-447.
176. Yamanouchi S., Kudo D., Yamada M., Miyagawa N., Furukawa H., Kushimoto S. Plasma mitochondrial DNA levels in patients with trauma and severe sepsis: time course and the association with clinical status. J. Crit. Care 2013, 28:1027-1031.
177. Yanai H., Matsuda A., An J., Koshiba R., Nishio J., Negishi H., Ikushima H., Onoe T., Ohdan H., Yoshida N., Taniguchi T. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:20699-20704.
178. Yang H., Hreggvidsdottir H.S., Palmblad K., Wang H., Ochani M., Li J., Lu B., Chavan S., Rosas-Ballina M., Al-Abed Y., Akira S., Bierhaus A., Erlandsson-Harris H., Andersson U., Tracey K.J. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11942-11947.
179. Yang H., Lundback P., Ottosson L., Erlandsson-Harris H., Venereau E., Bianchi M.E., Al-Abed Y., Andersson U., Tracey K.J., Antoine D.J. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol. Med. 2012, 18:250-259.
180. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., Susarla S.M., Ulloa L., Wang H., DiRaimo R., Czura C.J., Roth J., Warren H.S., Fink M.P., Fenton M.J., Andersson U., Tracey K.J. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:296-301.
181. Yang L., Xie M., Yang M., Yu Y., Zhu S., Hou W., Kang R., Lotze M.T., Billiar T.R., Wang H., Cao L., Tang D. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat. Commun. 2014, 5:4436.
182. Yang M., Cao L., Xie M., Yu Y., Kang R., Yang L., Zhao M., Tang D. Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis. Biochem. Pharmacol. 2013, 86:410-418.
183. Youn J.H., Kwak M.S., Wu J., Kim E.S., Ji Y., Min H.J., Yoo J.H., Choi J.E., Cho H.S., Shin J.S. Identification of lipopolysaccharide-binding peptide regions within HMGB1 and their effects on subclinical endotoxemia in a mouse model. Eur. J. Immunol. 2011, 41:2753-2762.
184. Youn J.H., Shin J.S. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 2006, 177:7889-7897.
185. Zeng L., Zhang A.Q., Gu W., Chen K.H., Jiang D.P., Zhang L.Y., Du D.Y., Hu P., Huang S.N., Wang H.Y., Jiang J.X. Clinical relevance of single nucleotide polymorphisms of the high mobility group box 1 protein gene in patients with major trauma in southwest China. Surgery 2012, 151:427-436.
186. Zhao Y., Huang Z.J., Rahman M., Luo Q., Thorlacius H. Radicicol, an Hsp90 inhibitor, inhibits intestinal inflammation and leakage in abdominal sepsis. J. Surg. Res. 2013, 182:312-318.
187. Zhu P., Duan L., Chen J., Xiong A., Xu Q., Zhang H., Zheng F., Tan Z., Gong F., Fang M. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Hum. Gene Ther. 2011, 22:853-864.
188. Zhu X.M., Yao Y.M., Liang H.P., Xu S., Dong N., Yu Y., Sheng Z.Y. The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats. J. Interferon Cytokine Res. 2009, 29:677-686.